EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseVergleichsstudieOpen Access · CC BY-NC-ND 4.0

Two-drug versus three-drug regimens for treating Mycobacterium avium complex infection: A systematic review and meta-analysis

Van-Dong Nguyen, Hai Duong, Ming-Chia Lee, Jin-Hua Chen, Wei-Chang Huang, Hsiao-En Chen, Jung-Chun Lin, Jann-Yuan Wang, Chih-Hsin Lee

Journal of Infection and Public Health · 2025-05 · 18 (5) · 102711

DOI: 10.1016/j.jiph.2025.102711 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Infection and Public Health, 2025-05. Verfasst von Van-Dong Nguyen und 8 weiteren Autor:innen. Beteiligte Einrichtung: International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Intensive Care Unit, Danang Hospital, Danang…. Hauptthemen laut MEDLINE: Mycobacterium avium-intracellulare Infection, Anti-Bacterial Agents, Mycobacterium avium Complex. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Mycobacterium avium complex (MAC) infection, requiring prolonged treatment with an antibiotic combination, is an emerging public health concern. METHODS: This meta-analysis compared the efficacy of 2-drug regimens with that of 3-drug regimens in bacteriological responses, acquired macrolide resistance (AMR), and mortality among adult patients with disseminated MAC infection (DMAC) and MAC pulmonary disease (MAC-PD). RESULTS: Seven randomized controlled trials (RCTs) and 3 non-RCT studies, encompassing 1369 patients, were included. Treating DMAC with 2-drug regimens was associated with comparable bacteriological responses (odds ratio (OR) = 0.76, 95 % confidence interval (CI) = 0.48-1.18, P = .22) and mortality (OR = 1.29, 95 % CI = 0.59-2.83, P = .52), but had a higher risk of AMR (OR = 2.99, 95 % CI = 1.10-8.13, P = .03). For MAC-PD, 2-drug regimens were noninferior to 3-drug regimens in bacteriological responses (OR = 0.82, 95 % CI = 0.53-1.25, P = .35) and AMR (risk differences (RD) = 0.01, -0.02 to 0.05, P = .39), with no observed mortalities. Although not statistically significant compared to the 3-drug regimen, the macrolide-rifamycin regimen resulted in attenuated bacteriological responses (OR = 0.51, 95 % CI = 0.14-1.90, P = .32). However, the proportion of patients with bacteriological response (OR = 1.54, 95 % CI = 0.78-2.93, P = .23) and AMR risk (RD = 0.01, -0.02 to 0.04, P = .50) was not different between those under the macrolide-ethambutol regimen and those under 3-drug regimens. CONCLUSIONS: The macrolide-ethambutol 2-drug regimen may be a viable alternative option for treating MAC-PD, whereas DMAC can be preferably managed with a 3-drug regimen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium avium-intracellulare InfectionAnti-Bacterial AgentsMycobacterium avium ComplexHumansDrug Therapy, CombinationTreatment OutcomeMacrolidesRandomized Controlled Trials as TopicDrug Resistance, Bacterial

Stichwörter der Autor:innen

2-drug regimen3-drug regimenMacrolideMycobacterium avium complexTreatment

Substanzen

Anti-Bacterial AgentsMacrolides

Autor:innen und Institutionen

  • International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; Intensive Care Unit, Danang Hospital, Danang, Viet Nam.
  • Department of Community Health, School of Medicine, Vietnam National University, Ho Chi Minh City, Viet Nam.
  • Department of Pharmacy, New Taipei City Hospital, New Taipei City, Taiwan; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan; Pulmonary Research Center, Wan Fang Hospital, Taipei Medical…
  • Pulmonary Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, Taiwan; Institutional Research Cente…
  • Division of Pulmonary Immunology & Infectious Diseases, Department of Chest Medicine, Taichung Veterans General Hospital, Taichung, Taiwan; Department of Post-Baccalaureate Medicine, College of Medicine, National Chung…
  • Pulmonary Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan; Division of Pulmonary Medicine, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.

Zitieren

APA

Nguyen, V. D., Duong, H., Lee, M. C., Chen, J. H., Huang, W. C., Chen, H. E., Lin, J. C., Wang, J. Y., & Lee, C. H. (2025). Two-drug versus three-drug regimens for treating Mycobacterium avium complex infection: A systematic review and meta-analysis. Journal of Infection and Public Health, 18(5), 102711. https://doi.org/10.1016/j.jiph.2025.102711

Vancouver

Nguyen VD, Duong H, Lee MC, Chen JH, Huang WC, Chen HE, et al. Two-drug versus three-drug regimens for treating Mycobacterium avium complex infection: A systematic review and meta-analysis. Journal of Infection and Public Health. 2025;18(5):102711. doi:10.1016/j.jiph.2025.102711

BibTeX
@article{Nguyen2025,
  author = {Nguyen, Van-Dong and Duong, Hai and Lee, Ming-Chia and Chen, Jin-Hua and Huang, Wei-Chang and Chen, Hsiao-En and Lin, Jung-Chun and Wang, Jann-Yuan and Lee, Chih-Hsin},
  title = {Two-drug versus three-drug regimens for treating Mycobacterium avium complex infection: A systematic review and meta-analysis},
  journal = {Journal of Infection and Public Health},
  year = {2025},
  volume = {18},
  number = {5},
  pages = {102711},
  doi = {10.1016/j.jiph.2025.102711}
}
Kostenlos starten →